Insulet (PODD) Misses Q3 EPS by 2c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus
Insulet (NASDAQ: PODD) reported Q3 EPS of $0.01, $0.02 worse than the analyst estimate of $0.03. Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
